OMER
OMEROS CORP
NASDAQ · Healthcare · Biotechnology · US
$18.17
−4.13%Forward multiples
Based on analyst estimates
- P/E forward
- 5.58x
- P/E 2026E
- 22.39x
- P/E 2027E
- 17.47x
- P/E 2028E
- 11.44x
- P/S forward
- 2.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- 9.51x
- PEG TTM
- 0.14x
- Price / book
- -25.61x
- Price / sales
- 34.23x
- Price / cash flow
- -19.15x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 32.98x
- EV / EBITDA
- 9.53x
- EV / EBIT
- -17.40x
- Market cap
- $1.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026